The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator Now Available in Canada

Thursday, May 10, 2012

Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator Now Available in Canada01:55 EDT Thursday, May 10, 2012 Device is the First Blood Glucose System in North America to Offer Mealtime Insulin Calculator TORONTO, May 9, 2012 /PRNewswire/ - Abbott today announced that its new FreeStyle InsuLinx Blood Glucose Monitoring System1 is now available in diabetes centres and select pharmacies across Canada. It is the first blood glucose monitoring device in North America that offers a mealtime insulin calculator for calculating suggested insulin doses. The FreeStyle InsuLinx System is designed to offer suggested insulin doses, as well as other features specifically intended to assist insulin-using patients in more effectively managing their diabetes. The user-friendly features include a touch screen interface, automated logbook, personalization preferences, and USB connectivity for plug-and-play reports. More than three million Canadians are living with diabetes2 and many of them require insulin to manage their condition. For those who use insulin, managing diabetes can often involve challenging calculations to determine an appropriate mealtime insulin dose. In a diabetes survey conducted in October 2011 by Leger Marketing, 200 Canadian healthcare professionals -- including general practitioners, diabetes nurse educators and endocrinologists -- stated that, in their respective clinics, four in ten mealtime insulin-using patients had difficulty calculating a mealtime insulin dose.3 Virtually all health care professionals (HCPs) surveyed (97%) believe that a patient's inability to manage insulin therapy limits the intensity and complexity of the therapy that an HCP can prescribe or recommend.4 "Insulin is a very important medication in the management of diabetes. While one of the most understood drugs available, if insulin is not dosed properly it can lead to serious consequences, most specifically hypoglycemia.  Fear of hypoglycemia leads to hesitancy to follow suggested insulin dose adjustments for both patients and health care providers," said Lori Berard, RN CDE Nurse Manager at the Health Sciences Centre Diabetes Research Group Clinical Research Program, affiliated with the University of Manitoba. "Some health care professionals are reluctant to prescribe insulin and/or intensify treatment as they are concerned that errors may occur when their patients are self adjusting their insulin. For people living with diabetes, they are often hesitant to self adjust.  It is encouraging that a product is available that may potentially assist some patients in their diabetes management. This could provide additional confidence for providers around proper insulin dosing to ensure patients are receiving the most effective therapy for their individual needs," said Berard. New Technology Designed to Help Insulin Users The FreeStyle InsuLinx System is the newest addition to Abbott's portfolio of glucose monitoring products and is designed for people with diabetes who use mealtime (rapid-acting) insulin. The system offers several features that are designed to enable insulin-using diabetes patients to more effectively manage their condition, including: Mealtime (rapid-acting) insulin calculator for calculating a suggested dose Touch screen designed for ease of use Automated logbook Personalization preferences, including weekly messages and pre- and post-meal markers, and the ability to upload a personal photograph to the FreeStyle InsuLinx monitor USB connectivity for plug-and-play reports FreeStyle Auto-Assist software, which is PC- and Mac-compatible, designed to help people with diabetes, health care teams and caregivers manage diabetes with reports, reminders and messages The FreeStyle InsuLinx Blood Glucose Monitoring System is compatible with the FreeStyle Lite blood glucose test strips with ZipWik tabs5 which are designed to offer easy blood application, resulting in a better blood glucose testing experience for people living with diabetes. Individuals with diabetes who are interested in the FreeStyle InsuLinx System should consult with their healthcare professional. This system is now broadly available at diabetes centres and select pharmacies in Canada. "We're pleased to introduce the FreeStyle InsuLinx Blood Glucose Monitoring System in Canada in an effort to assist with the day-to-day challenges endured by individuals with diabetes who use insulin," said Todd Nelson, General Manager, Abbott Diabetes Care Canada. "The FreeStyle InsuLinx Blood Glucose Monitoring System is the first innovative system in North America offering insulin calculation technology and new features specifically designed for insulin-using patients. This is a significant advance for the many patients in Canada who may benefit." Related Resources and Links FreeStyle InsuLinx System Media Site: - www.freestyleinsulinxmediakit.com Abbott Diabetes Care Canada: - www.abbottdiabetescare.ca/ About Abbott Diabetes Care Abbott Diabetes Care, based in Alameda, California, is a leader in developing, manufacturing and marketing glucose monitoring systems designed to help people better manage their diabetes. Additional information about Abbott Diabetes Care may be found at www.abbottdiabetescare.com. About Abbott Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs approximately 91,000 people and markets its products in more than 130 countries. Abbott has been operating in Canada since 1931 and its Canadian operations are headquartered in Montreal, Quebec. Abbott Canada employs more than 2,000 people. Abbott's news releases and other information are available on the company's Web sites at www.abbott.ca and www.abbott.com. 1 FreeStyle and related brand marks are trademarks of Abbott Diabetes Care, Inc. in various jurisdictions. 2 Diabetes Facts, Canadian Diabetes Association. Available at http://www.diabetes.ca/diabetes-and-you/what/facts/  Accessed 16 September, 2011 3  Leger Marketing Survey Data. Fleishman-Hillard's Diabetes Study. September, 2011. (41% of general practitioners, 44% of diabetes nurse educators, 36% of endocrinologists) 4  Leger Marketing Survey Data. Fleishman-Hillard's Diabetes Study. September, 2011. 5 In Canada, the FreeStyle InsuLinx Blood Glucose Monitoring System is compatible with FreeStyle Lite blood glucose monitoring test strips with ZipWik tabs. SOURCE AbbottVideo with caption: "Video:Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator Now Available in Canada ". Video available at: http://stream1.newswire.ca/cgi-bin/playback.cgi?file=20120509_C5640_VIDEO_EN_13402.mp4&posterurl=http://photos.newswire.ca/images/20120509_C5640_PHOTO_EN_13402.jpg&clientName=Abbott&caption=Video%3AAbbott%27s%20New%20FreeStyle%20InsuLinx%20Blood%20Glucose%20Monitoring%20System%20with%20Insulin%20Calculator%20Now%20Available%20in%20Canada%20&title=ABBOTT%20%2D%20Abbott%27s%20New%20FreeStyle%20InsuLinx%20Blood%20Glucose%20Monitoring%20System%20with%20Insulin%20Calculator%20Now%20Available%20in%20Canada&headline=Abbott%27s%20New%20FreeStyle%20InsuLinx%20Blood%20Glucose%20Monitoring%20System%20with%20Insulin%20Calculator%20Now%20Available%20in%20CanadaImage with caption: "FreeStyle InsuLinx Blood Glucose Monitor (CNW Group/Abbott)". Image available at: http://photos.newswire.ca/images/download/20120509_C5640_PHOTO_EN_13404.jpgAudio with caption: "Audio:Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator Now Available in Canada ". Audio available at: http://stream1.newswire.ca/media/2012/05/09/20120509_C5640_AUDIO_EN_13406.mp3PDF available at: http://stream1.newswire.ca/media/2012/05/09/20120509_C5640_DOC_EN_13524.pdfPDF available at: http://stream1.newswire.ca/media/2012/05/09/20120509_C5640_DOC_EN_13523.pdfFor further information: <p> English-Speaking <br/> Media: <br/> <b>Ann Smith </b><br font-weight="bold"></br> +1 (847) 937-6123 </p> <p> French-Speaking <br/> Media: <br/> <b>Eileen Murphy </b><br font-weight="bold"></br> +1 (514) 832-7788 </p> <p> Financial: <br/> <b>Tina Ventura </b><br font-weight="bold"></br> +1 (847) 935-9390 </p>